Web Desc
Tuberculosis Co-Morbidities and Immunopathogenesis
Organizer(s): Hardy Kornfeld, Sarah M. Fortune and Thomas R. Hawn
Date: February 28 - March 03, 2016
Location: Keystone Resort, Keystone, CO, USA
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.
Summary of Meeting:
Tuberculosis remains one of the most significant infectious disease threats to global health despite the availability of effective antimicrobials for more than 50 years. The focus of this Keystone Symposia meeting is on co-morbidities that are major driving factors in the TB pandemic and that may cause informative perturbations of immunity. This symposium explores metabolic disorders, environmental exposures, co-infections, age and genetic variants that influence host-pathogen interactions in TB. Plenary sessions will combine rather than separate topics focused on the host and the pathogen, and perspectives from laboratory and field studies. Speakers are encouraged to challenge existing dogma and offer new paradigms as a basis for more effective approaches to TB prevention and treatment.
Global Health Travel Award Deadline: September 29 2015
Scholarship Deadline: October 29 2015
Discounted Abstract Deadline: October 29 2015
Abstract Deadline: December 1 2015
Discounted Registration Deadline: January 5 2016
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Bill & Melinda Gates Foundation
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI122627-01
Funding for this conference was made possible (in part) by 1 R13 AI 122627 - 01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, February 28 | 4:00PM - 8:00PM
Arrival and Registration
Room: Longs Peak Foyer


Sunday, February 28 | 6:00PM - 8:00PM
Welcome Mixer
Room: Longs Peak Foyer
No registration fees are used to fund alcohol served at this function.

Monday, February 29 | 7:00AM - 8:00AM
Breakfast
Room: Longs/Quandary Peaks


Monday, February 29 | 8:00AM - 11:00AM
Metabolism and Co-Morbidity I
Room: Grays Peak

Speaker 1 of 6
* Eric J. Rubin, Harvard T.H. Chan School of Public Health, USA

Monday, February 29 | 8:00AM - 11:00AM
Metabolism and Co-Morbidity I
Room: Grays Peak

Speaker 2 of 6
Gökhan S. Hotamisligil, Harvard School of Public Health, USA
Immunometabolic Homeostasis and Metaflammation in Health and Disease

Monday, February 29 | 8:00AM - 11:00AM
Metabolism and Co-Morbidity I
Room: Grays Peak

Speaker 3 of 6
Larry S. Schlesinger, Texas Biomedical Research Institute, USA
A Convergence of Macrophage Inflammation and Metabolism

Monday, February 29 | 8:00AM - 11:00AM
Metabolism and Co-Morbidity I
Room: Grays Peak

Speaker 4 of 6
Kyu Y. Rhee, Weill Cornell Medical College, USA
Bacterial Metabolism in a Changing Host Environment

Monday, February 29 | 8:00AM - 11:00AM
Metabolism and Co-Morbidity I
Room: Grays Peak

Speaker 5 of 6
Sarah A. Stanley, University of California, Berkeley, USA
An Immune-Metabolic Program Regulated by HIF-1alpha and Nitric Oxide is Required for Control of M. tuberculosis

Monday, February 29 | 8:00AM - 11:00AM
Metabolism and Co-Morbidity I
Room: Grays Peak

Speaker 6 of 6
Noton K. Dutta, Johns Hopkins School of Medicine, USA
Short Talk: Statin Adjunctive Therapy Shortens the Duration of Tuberculosis Treatment in Mice

Monday, February 29 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Monday, February 29 | 11:00AM - 1:00PM
Poster Setup
Room: Longs/Quandary Peaks


Monday, February 29 | 11:00AM - 2:30PM
On Own for Lunch


Monday, February 29 | 1:00PM - 10:00PM
Poster Viewing
Room: Longs/Quandary Peaks


Monday, February 29 | 2:30PM - 4:30PM
Workshop 1: TB Risk Factors
Room: Grays Peak

Speaker 1 of 8
* Georgiana Purdy, Oregon Health & Sciences University, USA

Monday, February 29 | 2:30PM - 4:30PM
Workshop 1: TB Risk Factors
Room: Grays Peak

Speaker 2 of 8
Abul K. Azad, Ohio State University, USA
Defining the Genetic Basis for Biological Variation Among Donors in Human Macrophage Responses to Mycobacterium Tuberculosis

Monday, February 29 | 2:30PM - 4:30PM
Workshop 1: TB Risk Factors
Room: Grays Peak

Speaker 3 of 8
Anthony Michael Cadena, University of Pittsburgh School of Medicine, USA
Barcoding Mycobacterium Tuberculosis Reveals Local in vivo Infection Dynamics in the Macaque Model of Tuberculosis

Monday, February 29 | 2:30PM - 4:30PM
Workshop 1: TB Risk Factors
Room: Grays Peak

Speaker 4 of 8
Mark Hatherill, University of Cape Town, South Africa
A Phase 2 Randomized Controlled Trial of Safety and Immunogenicity of MVA85A and Selective, Delayed Bacille Calmette-Guerin (BCG) Vaccination in Infants of HIV Infected Mothers

Monday, February 29 | 2:30PM - 4:30PM
Workshop 1: TB Risk Factors
Room: Grays Peak

Speaker 5 of 8
David J. Horne, University of Washington, USA
Human ULK1 Variation and Susceptibility to Latent Tuberculosis Infection

Monday, February 29 | 2:30PM - 4:30PM
Workshop 1: TB Risk Factors
Room: Grays Peak

Speaker 6 of 8
Nuria Martinez, University of Massachusetts Medical School, USA
Impaired Innate Recognition of Mycobacterium tuberculosis by Alveolar Macrophages from Diabetic Mice

Monday, February 29 | 2:30PM - 4:30PM
Workshop 1: TB Risk Factors
Room: Grays Peak

Speaker 7 of 8
Juan I. Moliva, Vaccine Research Center, USA
Age-Associated Oxidation of Innate Immune Proteins in the Lung Mucosa Alters the Host Response to Mycobacterium tuberculosis

Monday, February 29 | 2:30PM - 4:30PM
Workshop 1: TB Risk Factors
Room: Grays Peak

Speaker 8 of 8
Ruijuan Zheng, Tongii University School of Medicine, China
Induction of Notch4 Negatively Regulate the Inflammatory responses to Mycobacterium Tuberculosis Infection

Monday, February 29 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Monday, February 29 | 5:00PM - 7:00PM
Genetic Variation: A Different Type of Co-Morbidity?
Room: Grays Peak

Speaker 1 of 5
* Ann M. Ginsberg, BMGF, USA

Monday, February 29 | 5:00PM - 7:00PM
Genetic Variation: A Different Type of Co-Morbidity?
Room: Grays Peak

Speaker 2 of 5
Thomas R. Hawn, University of Washington, USA
Innate Resistance to Mtb Infection

Monday, February 29 | 5:00PM - 7:00PM
Genetic Variation: A Different Type of Co-Morbidity?
Room: Grays Peak

Speaker 3 of 5
Igor B. Kramnik, Boston University, USA
Control of Lung Damage and Carcinogenesis in TB: Genes Meet the Microenvironment

Monday, February 29 | 5:00PM - 7:00PM
Genetic Variation: A Different Type of Co-Morbidity?
Room: Grays Peak

Speaker 4 of 5
Sarah M. Fortune, Harvard TH Chan School of Public Health, USA
Identifying the Drivers of Genetic Variation in Clinical Isolates of Mycobacterium tuberculosis

Monday, February 29 | 5:00PM - 7:00PM
Genetic Variation: A Different Type of Co-Morbidity?
Room: Grays Peak

Speaker 5 of 5
Maria Lerm, Linkoping University, Sweden
Short Talk: Epigenetic Reprogramming of Peripheral Blood Mononuclear Cells in BCG-Vaccinated Individuals

Monday, February 29 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Longs/Quandary Peaks
No registration fees are used to fund alcohol served at this function.

Monday, February 29 | 7:30PM - 10:00PM
Poster Session 1
Room: Longs/Quandary Peaks


Tuesday, March 01 | 7:00AM - 8:00AM
Breakfast
Room: Longs/Quandary Peaks


Tuesday, March 01 | 8:00AM - 11:15AM
HIV/TB Co-Morbidity
Room: Grays Peak

Speaker 1 of 7
* Michael Stephen Glickman, Memorial Sloan-Kettering Institute, USA

Tuesday, March 01 | 8:00AM - 11:15AM
HIV/TB Co-Morbidity
Room: Grays Peak

Speaker 2 of 7
Robert J. Wilkinson, University of Cape Town, South Africa
Understanding and Intervening in HIV-Associated Tuberculosis

Tuesday, March 01 | 8:00AM - 11:15AM
HIV/TB Co-Morbidity
Room: Grays Peak

Speaker 3 of 7
Anne E. Goldfeld, Children's Hospital Boston, Harvard Medical School, USA
Time is of the Essence: Lessons from the CAMELIA Trial

Tuesday, March 01 | 8:00AM - 11:15AM
HIV/TB Co-Morbidity
Room: Grays Peak

Speaker 4 of 7
Keertan Dheda, University of Cape Town, South Africa
New Insights into the Pathogenesis of Drug-Resistant TB and Implications for Clinical Management

Tuesday, March 01 | 8:00AM - 11:15AM
HIV/TB Co-Morbidity
Room: Grays Peak

Speaker 5 of 7
Philana Ling Lin, University of Pittsburgh, USA
Lesion Dynamics in SIV/TB Co-Infection

Tuesday, March 01 | 8:00AM - 11:15AM
HIV/TB Co-Morbidity
Room: Grays Peak

Speaker 6 of 7
Elisa Nemes, University of Cape Town, South Africa
Short Talk: Host Correlates of Risk of Bacille Calmette-Guerin (BCG) Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV+ Children Starting Antiretroviral Therapy (ART)

Tuesday, March 01 | 8:00AM - 11:15AM
HIV/TB Co-Morbidity
Room: Grays Peak

Speaker 7 of 7
Robert Blomgran, Linköping University, Sweden
Short Talk: HIV Interferes with Mycobacterium Tuberculosis Antigen Presentation in Human Dendritic Cells

Tuesday, March 01 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Tuesday, March 01 | 11:15AM - 1:00PM
Poster Setup
Room: Longs/Quandary Peaks


Tuesday, March 01 | 11:15AM - 2:30PM
On Own for Lunch


Tuesday, March 01 | 11:30AM - 12:15PM
Tips for Writing NIH Grant Applications: Navigating NIH Peer
Review
Room: Grays Peak

Speaker 1 of 1
* Raymond R. Schleef, NIAID, National Institutes of Health, USA

Tuesday, March 01 | 1:00PM - 10:00PM
Poster Viewing
Room: Longs/Quandary Peaks


Tuesday, March 01 | 2:30PM - 4:30PM
Workshop 2: Host-Pathogen Interactions
Room: Grays Peak

Speaker 1 of 7
* David M. Tobin, Duke University School of Medicine, USA

Tuesday, March 01 | 2:30PM - 4:30PM
Workshop 2: Host-Pathogen Interactions
Room: Grays Peak

Speaker 2 of 7
Eusondia Arnett, Texas Biomedical Research Institute, USA
Characterization of Virulence-Dependent AIM2 Expression, a PPAR-gamma effector in Human Macrophages During Mycobacterium Infection

Tuesday, March 01 | 2:30PM - 4:30PM
Workshop 2: Host-Pathogen Interactions
Room: Grays Peak

Speaker 3 of 7
Claire Dodd, Ohio State University, USA
Scavenger Receptor CD36 Mediates Uptake of Surfactant Lipids by Human Macrophages and Regulates Intracellular Growth of M. tuberculosis

Tuesday, March 01 | 2:30PM - 4:30PM
Workshop 2: Host-Pathogen Interactions
Room: Grays Peak

Speaker 4 of 7
Jan Philipp Korte, Heinrich-Heine University Düsseldorf, Germany
Trehalose-6-Phosphate Mediated Toxicity Determines Essentiality of OtsB2 in Mycobacterium Tuberculosis in vitro and in mice

Tuesday, March 01 | 2:30PM - 4:30PM
Workshop 2: Host-Pathogen Interactions
Room: Grays Peak

Speaker 5 of 7
Lenette Lu, Partners HealthCare, USA
Unique Functional Antibody Profiles in Latent and Active Tuberculosis Infection

Tuesday, March 01 | 2:30PM - 4:30PM
Workshop 2: Host-Pathogen Interactions
Room: Grays Peak

Speaker 6 of 7
Amanda J. Martinot, Tufts Cummings School of Veterinary Medicine, USA
“Fat is not Fit”: Targeting Lipid Transport in Drug Discovery for Mycobacterium tuberculosis

Tuesday, March 01 | 2:30PM - 4:30PM
Workshop 2: Host-Pathogen Interactions
Room: Grays Peak

Speaker 7 of 7
Amira Refai, Institut Pasteur de Tunis, Tunisia
Discrepancy Around Biological Functions of Mycobacterium tuberculosis Virulent factor ESAT-6 is due to two Distinct Conformational States of the Protein

Tuesday, March 01 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Tuesday, March 01 | 5:00PM - 7:00PM
Pediatrics: Is Immaturity a Co-Morbidity?
Room: Grays Peak

Speaker 1 of 5
* Thomas J. Scriba, University of Cape Town, South Africa

Tuesday, March 01 | 5:00PM - 7:00PM
Pediatrics: Is Immaturity a Co-Morbidity?
Room: Grays Peak

Speaker 2 of 5
Theodore H. Cohen, Yale School of Public Health, USA
Within-host Heterogeneity of M. tuberculosis Infection

Tuesday, March 01 | 5:00PM - 7:00PM
Pediatrics: Is Immaturity a Co-Morbidity?
Room: Grays Peak

Speaker 3 of 5
Deborah Lewinsohn, Oregon Health & Science University, USA
Pediatric Immunity in TB

Tuesday, March 01 | 5:00PM - 7:00PM
Pediatrics: Is Immaturity a Co-Morbidity?
Room: Grays Peak

Speaker 4 of 5
Helen McShane, Jenner Institute, UK
Vaccine Immunogenicity and Correlates of Protection in Infants and Adults

Tuesday, March 01 | 5:00PM - 7:00PM
Pediatrics: Is Immaturity a Co-Morbidity?
Room: Grays Peak

Speaker 5 of 5
Michael Shiloh, University of Texas Southwestern Medical Center, USA
Short Talk: Airway Microfold Cells Translocate Mycobacterium Tuberculosis to Initiate Infection

Tuesday, March 01 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Longs/Quandary Peaks
No registration fees are used to fund alcohol served at this function.

Tuesday, March 01 | 7:30PM - 10:00PM
Poster Session 2
Room: Longs/Quandary Peaks


Wednesday, March 02 | 7:00AM - 8:00AM
Breakfast
Room: Longs/Quandary Peaks


Wednesday, March 02 | 8:00AM - 11:00AM
Impact of Co-Infections on TB Pathogenesis
Room: Grays Peak

Speaker 1 of 6
* Shabaana A. Khader, Washington University School of Medicine, USA

Wednesday, March 02 | 8:00AM - 11:00AM
Impact of Co-Infections on TB Pathogenesis
Room: Grays Peak

Speaker 2 of 6
Alessandro Sette, La Jolla Institute for Immunology, USA
Comprehensive Immunophenotyping and Immunoprofiling of Epitope-Specific Responses.

Wednesday, March 02 | 8:00AM - 11:00AM
Impact of Co-Infections on TB Pathogenesis
Room: Grays Peak

Speaker 3 of 6
Subash S. Babu, National Institutes of Health - ICER, India
Modulation of Immune and Inflammatory Responses in Active Pulmonary Tuberculosis by Co-Incidental Helminth Infections

Wednesday, March 02 | 8:00AM - 11:00AM
Impact of Co-Infections on TB Pathogenesis
Room: Grays Peak

Speaker 4 of 6
Padmini Salgame, Rutgers University, USA
Helminth/TB Co-Infection: Th2 Cytokines

Wednesday, March 02 | 8:00AM - 11:00AM
Impact of Co-Infections on TB Pathogenesis
Room: Grays Peak

Speaker 5 of 6
Maziar Divangahi, McGill University, Canada
Influenza and Tuberculosis

Wednesday, March 02 | 8:00AM - 11:00AM
Impact of Co-Infections on TB Pathogenesis
Room: Grays Peak

Speaker 6 of 6
Jannike Blank, Research Center Borstel, Germany
Short Talk: One Episode of Self-resolving Plasmodium yoelii Infection Transiently Exacerbates Chronic Mycobacterium tuberculosis Infection

Wednesday, March 02 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Wednesday, March 02 | 11:00AM - 1:00PM
Poster Setup
Room: Longs/Quandary Peaks


Wednesday, March 02 | 11:00AM - 2:30PM
On Own for Lunch


Wednesday, March 02 | 1:00PM - 10:00PM
Poster Viewing
Room: Longs/Quandary Peaks


Wednesday, March 02 | 2:30PM - 4:30PM
Workshop 3: Host-Directed Therapy
Room: Grays Peak

Speaker 1 of 7
* Alan Sher, NIAID, National Institutes of Health, USA

Wednesday, March 02 | 2:30PM - 4:30PM
Workshop 3: Host-Directed Therapy
Room: Grays Peak

Speaker 2 of 7
Anna-Maria Andersson, Linköping University, Sweden
Autophagy Enhances Mycobacterium tuberculosis Replication in Latently and HIV Co-Infected Human Macrophages

Wednesday, March 02 | 2:30PM - 4:30PM
Workshop 3: Host-Directed Therapy
Room: Grays Peak

Speaker 3 of 7
Shashank Gupta, Johns Hopkins University, USA
ONTAK, a Recombinant Toxin, as a Host-Directed Therapy for Tuberculosis in the Mouse Model

Wednesday, March 02 | 2:30PM - 4:30PM
Workshop 3: Host-Directed Therapy
Room: Grays Peak

Speaker 4 of 7
Stefan H. Oehlers, Centenary Institute, Australia
Interception of Host Angiogenic Signaling Limits Mycobacterial Growth

Wednesday, March 02 | 2:30PM - 4:30PM
Workshop 3: Host-Directed Therapy
Room: Grays Peak

Speaker 5 of 7
Joseph Edward Qualls, Cincinnati Children's Hospital Medical Center, USA
Macrophage L-citrulline Metabolism Improves Anti-Mycobacterial Host Defense in vivo

Wednesday, March 02 | 2:30PM - 4:30PM
Workshop 3: Host-Directed Therapy
Room: Grays Peak

Speaker 6 of 7
Robindra Basu Roy, University of Oxford, UK
Evaluation of ibuprofen with Novel Whole Blood BCG GFP-luciferase Full Operon Assay

Wednesday, March 02 | 2:30PM - 4:30PM
Workshop 3: Host-Directed Therapy
Room: Grays Peak

Speaker 7 of 7
Javeed Ali Shah, University of Washington, USA
TOLLIP Deficiency is Associated with Increased Mycobacterium tuberculosis-specific Anti-Microbial Monocyte Responses and Protection from Pediatric Tuberculosis in South Africa

Wednesday, March 02 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Wednesday, March 02 | 5:00PM - 7:15PM
Metabolism and Co-Morbidity II
Room: Grays Peak

Speaker 1 of 6
* Blanca I. Restrepo, University of Texas HSC Houston, Brownsville Campus, USA

Wednesday, March 02 | 5:00PM - 7:15PM
Metabolism and Co-Morbidity II
Room: Grays Peak

Speaker 2 of 6
Megan Murray, Harvard Medical School, USA
Diabetes and Environmental Co-Morbidities with TB

Wednesday, March 02 | 5:00PM - 7:15PM
Metabolism and Co-Morbidity II
Room: Grays Peak

Speaker 3 of 6
Hazel M. Dockrell, London School Hygiene & Tropical Medicine, UK
Tuberculosis and Diabetes: Learning in TANDEM

Wednesday, March 02 | 5:00PM - 7:15PM
Metabolism and Co-Morbidity II
Room: Grays Peak

Speaker 4 of 6
Hardy Kornfeld, University of Massachusetts Medical School, USA
Cellular Immunology of TB Susceptibility with Metabolic Co-Morbidities

Wednesday, March 02 | 5:00PM - 7:15PM
Metabolism and Co-Morbidity II
Room: Grays Peak

Speaker 5 of 6
Satyanarayana Swamy Cheekatla, University of Texas Health N.E., USA
Short Talk: Nk-dc Crosstalk in Diabetes Enhances il-6 Mediated Inflammation during Tuberculosis Infection

Wednesday, March 02 | 5:00PM - 7:15PM
Metabolism and Co-Morbidity II
Room: Grays Peak

Speaker 6 of 6
Anil Kumar Ojha, Wadsworth Center, University at Albany, USA
Short Talk: Ribosomal Heterogeneity Determines Biofilm Development and Drug Tolerance in Mycobacteria

Wednesday, March 02 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Longs/Quandary Peaks
No registration fees are used to fund alcohol served at this function.

Wednesday, March 02 | 7:30PM - 10:00PM
Poster Session 3
Room: Longs/Quandary Peaks


Thursday, March 03 | 7:00AM - 8:00AM
Breakfast
Room: Longs/Quandary Peaks


Thursday, March 03 | 8:00AM - 11:15AM
Host-Pathogen Interactions
Room: Grays Peak

Speaker 1 of 6
* Priscille Marie Brodin, CIIL Institut Pasteur, France
Small Molecules Targeting Host Against M. tuberculosis

Thursday, March 03 | 8:00AM - 11:15AM
Host-Pathogen Interactions
Room: Grays Peak

Speaker 2 of 6
Shabaana A. Khader, Washington University School of Medicine, USA
Neutrophils in TB: The Good, the Bad and the Ugly

Thursday, March 03 | 8:00AM - 11:15AM
Host-Pathogen Interactions
Room: Grays Peak

Speaker 3 of 6
Jeffery S. Cox, University of California, Berkeley, USA
Discrimination of Pathogens from Non-Pathogens by Innate Immune Cells

Thursday, March 03 | 8:00AM - 11:15AM
Host-Pathogen Interactions
Room: Grays Peak

Speaker 4 of 6
Joseph Keane, Trinity College Dublin, Ireland
Effects of Cigarette Smoke on the Macrophage-Pathogen Interaction

Thursday, March 03 | 8:00AM - 11:15AM
Host-Pathogen Interactions
Room: Grays Peak

Speaker 5 of 6
Jacqueline M. Kimmey, Washington University, USA
Short Talk: Unique Role for ATG5 in PMN-Mediated Immunopathology during M. tuberculosis Infection

Thursday, March 03 | 8:00AM - 11:15AM
Host-Pathogen Interactions
Room: Grays Peak

Speaker 6 of 6
Joanne Turner, Texas Biomedical Research Instutite, USA
Short Talk: A Mouse Model of Age-Associated Tuberculosis Reactivation Positions KLRG1 as a Modulator of Disease Progression

Thursday, March 03 | 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer


Thursday, March 03 | 11:15AM - 5:00PM
On Own for Lunch


Thursday, March 03 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Thursday, March 03 | 5:00PM - 6:45PM
Host-Directed Therapeutics: Co-Opting Treatment of Co-Morbid
ities

Room: Grays Peak

Speaker 1 of 4
* Anna Kathleen Coussens, Walter and Eliza Hall Institute, Australia

Thursday, March 03 | 5:00PM - 6:45PM
Host-Directed Therapeutics: Co-Opting Treatment of Co-Morbid
ities

Room: Grays Peak

Speaker 2 of 4
Amit Singhal, Singapore Immunology Network, Singapore
Intervening Host Immunometabolic Program: Potential for TB HDT

Thursday, March 03 | 5:00PM - 6:45PM
Host-Directed Therapeutics: Co-Opting Treatment of Co-Morbid
ities

Room: Grays Peak

Speaker 3 of 4
Guy Edward Thwaites, Oxford University Clinical Research Unit, Vietnam
Personalised Adjunctive Anti-Inflammatory Therapy for Tuberculosis

Thursday, March 03 | 5:00PM - 6:45PM
Host-Directed Therapeutics: Co-Opting Treatment of Co-Morbid
ities

Room: Grays Peak

Speaker 4 of 4
Adrian R. Martineau, Queen Mary University of London, UK
Vitamin D and Phenylbutyrate as Potential Host-Directed Therapies

Thursday, March 03 | 6:45PM - 7:00PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Grays Peak


Thursday, March 03 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Longs/Quandary Peaks
No registration fees are used to fund alcohol served at this function.

Thursday, March 03 | 8:00PM - 11:00PM
Entertainment
Room: Longs/Quandary Peaks
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Thursday, March 03 | 8:00PM - 11:00PM
Cash Bar
Room: Longs/Quandary Peaks


Friday, March 04 | 10:25AM - 10:25AM
Departure


*Session Chair.